文献速递血栓与止血

靶向长距离聚合酶链反应与长读长测序分析在血友病中的临床验证与应用:来自中国一家血友病治疗中心的经验

Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing-based analysis for hemophilia: experience from a hemophilia treatment center in China.
PubMed 文献 · J Thromb Haemost · 2024-09-12

该研究回顾性和前瞻性分析了122例血友病患者的基因变异,评估靶向长读长测序(LRS)相比常规PCR方法的临床适用性。在90例血友病A回顾性分析中,84例结果与常规方法一致,并明确了6例大片段缺失的精确断点;前瞻性分析21例血友病A中20例检出F8变异,另1例经全基因组测序确定涉及F8外显子14至21的30 478 bp串联重复;11例血友病B中检出11个F9 SNV/InDel,与常规方法一致。结论认为靶向LRS高效全面,但复杂大片段重排仍需进一步研究。

要点

  • 靶向LRS在84例血友病A中与常规方法结果一致,并明确了6例大片段缺失的精确断点。
  • 1例血友病A经LRS发现F8外显子14和21潜在重组,全基因组测序确定30 478 bp串联重复。
  • 11例血友病B中检出11个F9 SNV/InDel,与常规方法一致。

核心结论

  • 靶向LRS分析能高效、全面地识别血友病基因的SNV/InDel和基因组重排,尤其在首次将F9纳入检测面板时。
  • 对于复杂的大片段重排,仍需进一步研究。

研究设计与样本

  • 回顾性和前瞻性分析已检索受试者的基因变异,共检索122例受试者。
  • 对未诊断病例进一步行全基因组测序,并用长距离PCR和长片段PCR结合测序定位和验证新发基因组重排的断点。

主要发现

  • 回顾性分析90例血友病A中,靶向LRS检测在84例与常规方法结果一致,并在6例中鉴定出大片段缺失及其精确断点,常规方法仅表现为无法扩增受累外显子。
  • 前瞻性分析21例血友病A中,20例检出20个F8变异;剩余1例未发现重复/缺失或SNV/InDel,但LRS观察到涉及F8外显子14和21的潜在重组,全基因组测序和进一步验证确定为涉及F8外显子14至21的30 478 bp串联重复。
  • 11例血友病B中,靶向LRS检测到11个F9 SNV/InDel,与常规方法一致。

局限性

  • 对于复杂的大片段重排,仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Targeted long-read sequencing (LRS) is expected to comprehensively analyze diverse complex variants in hemophilia A (HA) and hemophilia B (HB) caused by the F8 and F9 genes, respectively. However, its clinical applicability still requires extensive validation. OBJECTIVES: To evaluate the clinical applicability of targeted LRS-based analysis compared with routine polymerase chain reaction (PCR)-based methods. METHODS: Gene variants of retrieved subjects were retrospectively and prospectively analyzed. Whole-genome sequencing was performed to further analyze undiagnosed cases. Breakpoints of novel genomic rearrangements were mapped and validated using long-distance PCR and long-range PCR combined with sequencing. RESULTS: In total, 122 subjects were retrieved. In retrospective analysis of the 90 HA cases, HA-LRS assay showed consistent results in 84 cases compared with routine methods and characterized 6 large deletions with their exact breakpoints confirmed by further validation in 6 cases (routine methods only presented failure in amplifying the involved exons). In prospective analysis of the 21 HA subjects, 20 variants of F8 were identified in 20 cases. For the remaining HA patient, no duplication/deletion or single-nucleotide variant (SNV)/insertion and deletion (InDel) was found, but a potential recombination involving exons 14 and 21 of F8 was observed by LRS. Whole-genome sequencing analysis and further verification defined a 30 478 base pairs (bp) tandem repeat involving exons 14 to 21 of F8. Among the 11 HB patients, HB-LRS analysis detected 11 SNVs/InDels in F9, consistent with routine methods. CONCLUSION: Targeted LRS-based analysis was efficient and comprehensive in identifying SNVs/InDels and genomic rearrangements of hemophilia genes, especially when we first expanded the panel to include F9. However, further investigation for complex gross rearrangement is still essential.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Shi M, Ma Y, Peng X, et al. Clinical validation and application of targeted long-range polymerase chain reaction and long-read sequencing-based analysis for hemophilia: experience from a hemophilia treatment center in China. J Thromb Haemost. 2024. PMID: 39260745. doi:10.1016/j.jtha.2024.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。